In silico Study of the Antidiabetic Potential of Alkaloid Compounds from the Roots of Acalypha indica: Molecular Docking and ADMET Prediction

Authors

DOI:

https://doi.org/10.35451/j5150f91

Keywords:

Acalypha indica, Alkaloid, α-Glucosidase, Molekular Docking, ADMET

Abstract

Oral Type 2 Diabetes Mellitus (T2DM) therapy gastrointestinal side effects encouraged bioactive alternative exploration via Acalypha indica root alkaloids. This study aimed to evaluate Acalypha indica root alkaloids detected by LC-HRMS against α-glucosidase using molecular docking and ADMET evaluation. Ligand structures were optimized via ChemDraw 3D while 2QMJ receptor preparation was conducted using Discovery Studio Client and AutoDock Tools. Parameters were validated through redocking with RMSD <2 Å. Molecular docking was performed using AutoDock Vina with interaction visualization via Discovery Studio Visualizer and PyMOL while pharmacokinetic profiles were predicted using ADMETlab. Results identify compound (1) as the most potent inhibitor with ΔG -9.47 kcal/mol surpassing acarbose stability. Visualizations confirm hydrophobic interaction strengthening at key catalytic residues Asp443 and Asp542 indicating a competitive inhibition mechanism. Compound (1) selection as the primary candidate is based on high affinity and genotoxic safety due to mutagenicity absence in AMES parameters. Compound (1) ADMET characteristics show low intestinal permeability advantageous for local action in the intestinal lumen similar to acarbose. This study recommends compound (1) as a potential antidiabetic candidate for further testing although structural optimization is required to mitigate organ toxicity risks at advanced clinical stages.

Downloads

Download data is not yet available.

References

[1] Kalinovskii AP, Sintsova O V., Gladkikh IN, Leychenko E V. Natural Inhibitors of Mammalian α-Amylases as Promising Drugs for the Treatment of Metabolic Diseases. Int J Mol Sci 2023;24. https://doi.org/10.3390/ijms242216514.

[2] Dhameja M, Gupta P. Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview. Eur J Med Chem 2019;176:343–77.

[3] Rasouli H, Yarani R, Pociot F, Popović-Djordjević J. Anti-diabetic potential of plant alkaloids: Revisiting current findings and future perspectives. Pharmacol Res 2020;155:104723.

[4] Zahidin NS, Saidin S, Zulkifli RM, Muhamad II, Ya’akob H, Nur H. A review of Acalypha indica L. (Euphorbiaceae) as traditional medicinal plant and its therapeutic potential. J Ethnopharmacol 2017;207:146–73. https://doi.org/https://doi.org/10.1016/j.jep.2017.06.019.

[5] Hayati EK, Aulanni’am, Sabarudin A, Rafi M, Karomah AH. LCHRMS-based metabolomics on Acalypha indica with different altitude and antioxidant activity. South African Journal of Botany 2024;172:710–9. https://doi.org/https://doi.org/10.1016/j.sajb.2024.07.064.

[6] Hakim RW, Fadilah F, Tarigan TJE, Jusman SWA, Purwaningsih EH. Molecular Study of Acalypha indica to Leptin, Alpha Glucosidase, and its Antihyperglycemic Effect on Alpha Glucosidase. Pharmacognosy Journal 2021;13:1639–47. https://doi.org/10.5530/pj.2021.13.211.

[7] Sahukari R, Punabaka J, Bhasha S, Ganjikunta VS, Ramudu SK, Kesireddy SR, Ye W, Korivi M. Phytochemical profile, free radical scavenging and anti-inflammatory properties of Acalypha Indica root extract: Evidence from in vitro and in vivo studies. Molecules 2021;26. https://doi.org/10.3390/molecules26206251.

[8] Fajarini SR, Amin S, Ansyirohanisa, Beni Maulana Habib, Muhammad Rahmat Darmawan. From Laboratory to Algorithm: The Role of Computational Methods in New Drug Design Discovery in the Digital Era. JURNAL FARMASIMED (JFM) 2025;8:1–10. https://doi.org/10.35451/8f4xh746.

[9] Vittorio S, Lunghini F, Morerio P, Gadioli D, Orlandini S, Silva P, Martinovic J, Pedretti A, Bonanni D, Del Bue A. Addressing docking pose selection with structure-based deep learning: recent advances, challenges and opportunities. Comput Struct Biotechnol J 2024;23:2141–51.

[10] Azzahrah QA, Novelina L, Rosviena NAF, Saabirah GP, Adilla AR, Saeli PM, Uswatunhasanah P, Auli WN, Saputro AH. Molecular Docking of Flavonoid Compounds and Some of Their Derivatives in Gandaria (Bouea macrophlla Griff) as Antidiabetic on Glucoamulase Maltase Enzyme. Pharmacy Reports 2025;4:75. https://doi.org/10.51511/pr.75.

[11] Elferink H, Bruekers JPJ, Veeneman GH, Boltje TJ. A comprehensive overview of substrate specificity of glycoside hydrolases and transporters in the small intestine. Cellular and Molecular Life Sciences 2020;77:4799–826. https://doi.org/10.1007/s00018-020-03564-1.

[12] Sim L, Quezada-Calvillo R, Sterchi EE, Nichols BL, Rose DR. Human Intestinal Maltase–Glucoamylase: Crystal Structure of the N-Terminal Catalytic Subunit and Basis of Inhibition and Substrate Specificity. J Mol Biol 2008;375:782–92. https://doi.org/10.1016/j.jmb.2007.10.069.

[13] Madushanka A, Moura RT, Verma N, Kraka E. Quantum Mechanical Assessment of Protein–Ligand Hydrogen Bond Strength Patterns: Insights from Semiempirical Tight-Binding and Local Vibrational Mode Theory. Int J Mol Sci 2023;24:6311. https://doi.org/10.3390/ijms24076311.

[14] Kashtoh H, Baek K-H. Recent Updates on Phytoconstituent Alpha-Glucosidase Inhibitors: An Approach towards the Treatment of Type Two Diabetes. Plants 2022;11:2722. https://doi.org/10.3390/plants11202722.

[15] Iqbal MJ, Senra MVX, Villegas C, Burgos V, Paz C. Integrated computational and experimental evaluation of grossamide as a natural product scaffold for dual carbohydrase inhibition in diabetes. J Comput Aided Mol Des 2025;39:122. https://doi.org/10.1007/s10822-025-00704-2.

[16] Kamel EM, Alkhayl FFA, Alqhtani HA, Bin-Jumah M, Rudayni HA, Lamsabhi AM. Dissecting molecular mechanisms underlying the inhibition of β-glucuronidase by alkaloids from Hibiscus trionum: Integrating in vitro and in silico perspectives. Comput Biol Med 2024;180:108969. https://doi.org/10.1016/j.compbiomed.2024.108969.

[17] Rossafi B, Abchir O, Guerguer F, Abass KS, Yamari I, El Kouali M, Samadi A, Chtita S. Structure-Based Virtual Screening and In Silico Evaluation of Marine Algae Metabolites as Potential α-Glucosidase Inhibitors for Antidiabetic Drug Discovery. Pharmaceuticals 2026;19:98. https://doi.org/10.3390/ph19010098.

[18] Bitencourt-Ferreira G, de Azevedo Junior WF. Electrostatic Potential Energy in Protein-Drug Complexes. Curr Med Chem 2021;28:4954–71. https://doi.org/10.2174/0929867328666210201150842.

[19] Patil R, Das S, Stanley A, Yadav L, Sudhakar A, Varma AK. Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing. PLoS One 2010;5:e12029. https://doi.org/10.1371/journal.pone.0012029.

[20] Singh J, Jindal N, Kumar V, Singh K. Role of green chemistry in synthesis and modification of graphene oxide and its application: A review study. Chemical Physics Impact 2023;6:100185. https://doi.org/https://doi.org/10.1016/j.chphi.2023.100185.

[21] Iqbal MJ, Malik I, Bernal G, Salas-Burgos AM, Salazar LA. Computational-experimental integration identifies potent carbohydrate-hydrolyzing enzyme inhibitors from Nardostachys jatamansi: molecular docking, dynamics and pharmacokinetic predictions. Front Pharmacol 2026;16. https://doi.org/10.3389/fphar.2025.1713452.

[22] Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development. Adv Drug Deliv Rev 2001;46:3–26. https://doi.org/10.1016/S0169-409X(00)00129-0.

[23] Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717. https://doi.org/10.1038/srep42717.

[24] Fedi A, Vitale C, Ponschin G, Ayehunie S, Fato M, Scaglione S. In vitro models replicating the human intestinal epithelium for absorption and metabolism studies: A systematic review. Journal of Controlled Release 2021;335:247–68. https://doi.org/10.1016/j.jconrel.2021.05.028.

[25] Zheng X, Zhang Z, Xie J. The effect of acarbose on the gut microbiota: an evidence-based review. Frontiers in Medical Science Research 2021;3. https://doi.org/10.25236/FMSR.2021.030302.

[26] Saib S, Delavenne X. Inflammation induces changes in the functional expression of P-gp, BCRP, and MRP2: an overview of different models and consequences for drug disposition. Pharmaceutics 2021;13:1544.

[27] Stielow M, Witczyńska A, Kubryń N, Fijałkowski Ł, Nowaczyk J, Nowaczyk A. The Bioavailability of Drugs—The Current State of Knowledge. Molecules 2023;28:8038. https://doi.org/10.3390/molecules28248038.

[28] Puris E, Fricker G, Gynther M. Targeting Transporters for Drug Delivery to the Brain: Can We Do Better? Pharm Res 2022;39:1415–55. https://doi.org/10.1007/s11095-022-03241-x.

[29] Bhagwat SK, Patil S V., Vidal-Limon A, Jimenez-Halla JOC, Ghotekar BK, Bobade VD, Pérez-Landa ID, Delgado-Alvarado E, Hernández-Rosas F, Pawar TJ. Design and Evaluation of Indole-Based Schiff Bases as α-Glucosidase Inhibitors: CNN-Enhanced Docking, MD Simulations, ADMET Profiling, and SAR Analysis. Molecules 2025;30:3651. https://doi.org/10.3390/molecules30173651.

[30] Parsons BL, Beal MA, Dearfield KL, Douglas GR, Gi M, Gollapudi BB, Heflich RH, Horibata K, Kenyon M, Long AS, Lovell DP, Lynch AM, Myers MB, Pfuhler S, Vespa A, Zeller A, Johnson GE, White PA. Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing. Environ Mol Mutagen 2024. https://doi.org/10.1002/em.22599.

[31] Zeiger E. The test that changed the world: The Ames test and the regulation of chemicals. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2019;841:43–8. https://doi.org/10.1016/j.mrgentox.2019.05.007.

Downloads

Published

2026-04-30

How to Cite

In silico Study of the Antidiabetic Potential of Alkaloid Compounds from the Roots of Acalypha indica: Molecular Docking and ADMET Prediction. (2026). JURNAL FARMASIMED (JFM), 8(2), 740-750. https://doi.org/10.35451/j5150f91